PRKN and cancer: Specifically, studies on mitophagy-related proteins, such as those involved in the PINK1/Parkin and BNIP3/NIX pathways, offer potential avenues to modulate mitophagy levels, thereby influencing tumor cell survival and proliferation, and providing new hope for cancer treatment (59, 60).